F.D.A. Grants Early Access to Promising Drug for Pancreatic Cancer
Patients with one of the deadliest cancers have been pleading [...]
The early FDA approval doesn’t…
The early FDA approval doesn’t change Pfizer and Arvinas’ plan [...]
Top Psychiatrists Call for a Greater Focus on Ceasing Medication
With Health Secretary Robert F. Kennedy Jr. aiming to rein [...]
As Eli Lilly gets off to the races…
As Eli Lilly gets off to the races with the [...]
Bristol Myers Squibb’s growth…
Bristol Myers Squibb’s growth portfolio is offsetting declines in older [...]
While Merck’s PAH treatment…
While Merck’s PAH treatment Winrevair continued its upward trajectory, another [...]
As AstraZeneca braces for the…
As AstraZeneca braces for the impact of the U.S. “most [...]
While Teva Pharmaceutical’s…
While Teva Pharmaceutical’s multiyear growth streak under CEO Richard Francis [...]
Immunology med Skyrizi charted…
Immunology med Skyrizi charted sales growth of 30.9% over 2026’s [...]
Novartis CEO Vas Narasimhan says…
Novartis CEO Vas Narasimhan says that Europe needs a “complete [...]